|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/711 | |||
| C07H 21/00 | |||
| A61P 25/00 | |||
| A61P 27/02 |
| (11) | Patento numeris | 1699924 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04817632.5 |
| Europos patento paraiškos padavimo data | 2004-12-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-09-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2004/004431 |
| Data | 2004-12-03 |
| (87) | Numeris | WO 2005/053600 |
| Data | 2005-06-16 |
| (30) | Numeris | Data | Šalis |
| 529936 | 2003-12-03 | NZ |
| (72) |
LAUX, Wilda, NZ
GREEN, Colin, R., NZ
|
| (73) |
Ocunexus Therapeutics, Inc.,
101 West Broadway, Suite 900, San Diego, CA 92101,
US
|
| (54) | INHIBITORY COMPOUNDS TARGETED TO CONNEXIN 43 AND METHODS OF USE THEREOF IN THE TREATMENT OF CORNEAL EYE TRAUMA |
| INHIBITORY COMPOUNDS TARGETED TO CONNEXIN 43 AND METHODS OF USE THEREOF IN THE TREATMENT OF CORNEAL EYE TRAUMA |